Overview

A Study in Healthy Men to Compare the Amount of Vicadrostat and Empagliflozin in the Blood When Taken Separately and Together

Status:
COMPLETED

Trial end date:
2025-08-15

Target enrollment:

Participant gender:

Summary

The main objective of this trial is to investigate the relative bioavailability of vicadrostat and empagliflozin when administered in combination or individually.

Phase:

PHASE1

Details

Lead Sponsor:

Boehringer Ingelheim

Treatments:

empagliflozin